“…The management of P. agglomerans infections in neonates presents a formidable challenge owing to its propensity for resistance against a broad spectrum of antibiotics [6]. Available evidence points out the resistance of P. agglomerans to multiple antibiotic classes, encompassing early-generation penicillins, cephalosporins, fluoroquinolones, aminoglycosides, trimethoprim/sulfamethoxazole, and tetracyclines.…”